A Phase 1 Study of NRM-823 in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

ClinicalTrials.gov ID: NCT07182149

Public ClinicalTrials.gov record NCT07182149. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 20, 2026, 11:43 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 1a/1b Study of NRM-823 as Monotherapy and in Combination With Immune Checkpoint Inhibition in Participants With Locally Advanced or Metastatic Refractory Solid Tumors

Study identification

NCT ID: NCT07182149
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 1
Lead sponsor: Normunity AccelCo, Inc.; Industry
Enrollment: 150 participants

Conditions and interventions

Conditions

Interventions

NRM-823 Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Oct 29, 2025
Primary completion: May 29, 2027
Completion: Oct 30, 2028
Last update posted: Feb 11, 2026

2025 – 2028

United States locations

U.S. sites: 9
U.S. states: 8
U.S. cities: 9

Facility	City	State	ZIP	Site status
Normunity Investigational Site	Denver	Colorado	80220	Recruiting
Normunity Investigational Site	New Haven	Connecticut	06519	Recruiting
Normunity Investigational Site	Minneapolis	Minnesota	55425	Recruiting
Normunity Investigational Site	Maumee	Ohio	43537	Recruiting
Normunity Investigational Site	Philadelphia	Pennsylvania	19107	Recruiting
Normunity Investigational Site	Nashville	Tennessee	37203	Recruiting
Normunity Investigational Site	Dallas	Texas	75230	Recruiting
Normunity Investigational Site	San Antonio	Texas	78229	Recruiting
Normunity Investigational Site	Fairfax	Virginia	22031	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07182149, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Feb 11, 2026 · Synced May 20, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07182149 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →